Screener
Insulet PODD EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Insulet’s reported figures.
The source filing: Insulet’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001145197-26-000169
FAQ
- What is Insulet's EBITDA?
- Insulet (PODD) reported EBITDA of $156.4M in Q2 2026.
- How has Insulet's EBITDA changed year-over-year?
- Insulet's EBITDA increased by 9.1% year-over-year, from $143.4M to $156.4M.
- What is the long-term trend for Insulet's EBITDA?
- Over 4 years (2021 to 2025), Insulet's EBITDA has grown at a 32.4% compound annual growth rate (CAGR), from $183.4M to $564.3M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Insulet's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude